These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30108156)

  • 61. Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.
    Galanina N; Bejar R; Choi M; Goodman A; Wieduwilt M; Mulroney C; Kim L; Yeerna H; Tamayo P; Vergilio JA; Mughal TI; Miller V; Jamieson C; Kurzrock R
    Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30583461
    [No Abstract]   [Full Text] [Related]  

  • 62. Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma.
    Havranek O; Spacek M; Hubacek P; Mocikova H; Markova J; Trneny M; Kleibl Z
    Neoplasma; 2011; 58(5):392-5. PubMed ID: 21744992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Preliminary analysis of mutations in exon 5 of IkappaBalpha gene in Hodgkin lymphoma].
    Liu XJ; Yang WT; Zhou XY; Yan Q; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):341-4. PubMed ID: 16185501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis.
    Zhao L; Luo B; Wang L; Chen W; Jiang M; Zhang N
    Transl Cancer Res; 2021 Nov; 10(11):4664-4679. PubMed ID: 35116322
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers.
    Wang M; Fan W; Ye M; Tian C; Zhao L; Wang J; Han W; Yang W; Gu C; Li M; Zhang Z; Wang Y; Zhang H; Meng Y
    Sci Rep; 2018 Jun; 8(1):8990. PubMed ID: 29895933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
    Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
    Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling.
    Vanhentenrijk V; Vanden Bempt I; Dierickx D; Verhoef G; Wlodarska I; De Wolf-Peeters C
    J Pathol; 2006 Oct; 210(2):155-62. PubMed ID: 16874743
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
    Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
    Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma.
    Cheng Y; Zhang Y; Yuan Y; Wang J; Liu K; Yu B; Xie L; Ou-Yang C; Wu L; Ye X
    Front Genet; 2020; 11():609405. PubMed ID: 33679868
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell-Specific Long Noncoding RNAs.
    Tayari MM; Winkle M; Kortman G; Sietzema J; de Jong D; Terpstra M; Mestdagh P; Kroese FG; Visser L; Diepstra A; Kok K; van den Berg A; Kluiver J
    Am J Pathol; 2016 Sep; 186(9):2462-72. PubMed ID: 27423697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
    De Falco V; Poliero L; Vitello PP; Ciardiello D; Vitale P; Zanaletti N; Giunta EF; Terminiello M; Caputo V; Carlino F; Di Liello R; Ventriglia A; Famiglietti V; Martinelli E; Morgillo F; Orditura M; De Vita F; Fasano M; Napolitano S; Martini G; Della Corte CM; Franco R; Altucci L; Ciardiello F; Troiani T
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32234730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.
    Giulino-Roth L; Wang K; MacDonald TY; Mathew S; Tam Y; Cronin MT; Palmer G; Lucena-Silva N; Pedrosa F; Pedrosa M; Teruya-Feldstein J; Bhagat G; Alobeid B; Leoncini L; Bellan C; Rogena E; Pinkney KA; Rubin MA; Ribeiro RC; Yelensky R; Tam W; Stephens PJ; Cesarman E
    Blood; 2012 Dec; 120(26):5181-4. PubMed ID: 23091298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors.
    Bou Zerdan M; Kumar PA; Zaccarini D; Ross J; Huang R; Sivapiragasam A
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic mutation characteristics and prognosis of biliary tract cancer.
    Guo L; Zhou F; Liu H; Kou X; Zhang H; Chen X; Qiu J
    Am J Transl Res; 2022; 14(7):4990-5002. PubMed ID: 35958441
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recurrent genetic defects in classical Hodgkin lymphoma cell lines.
    Hudnall SD; Meng H; Lozovatsky L; Li P; Strout M; Kleinstein SH
    Leuk Lymphoma; 2016 Dec; 57(12):2890-2900. PubMed ID: 27121023
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice.
    Čerina D; Matković V; Katić K; Lovasić IB; Šeparović R; Canjko I; Jakšić B; Fröbe A; Pleština S; Bajić Ž; Vrdoljak E
    Pathol Oncol Res; 2021; 27():1609963. PubMed ID: 34646088
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
    Sánchez-Aguilera A; Montalbán C; de la Cueva P; Sánchez-Verde L; Morente MM; García-Cosío M; García-Laraña J; Bellas C; Provencio M; Romagosa V; de Sevilla AF; Menárguez J; Sabín P; Mestre MJ; Méndez M; Fresno MF; Nicolás C; Piris MA; García JF;
    Blood; 2006 Jul; 108(2):662-8. PubMed ID: 16551964
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population.
    Nakamura K; Urabe Y; Kagemoto K; Yuge R; Hayashi R; Ono A; Hayes CN; Oka S; Ito M; Nishisaka T; Tanabe K; Arihiro K; Ohdan H; Tanaka S; Chayama K
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098350
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial.
    Hu Q; Oki E; Yamada T; Kashiwada T; Sonoda H; Kataoka M; Kawanaka H; Tsuji Y; Makiyama A; Nakashima Y; Ota M; Kimura Y; Yoshizumi T
    Cancer Med; 2023 Aug; 12(15):16649-16660. PubMed ID: 37325934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.